Hybrid oligomers, their preparation process and pharmaceutical compositions containing them
US7691807B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Mar 17, 2006 |
| Grant date | Apr 6, 2010 |
| Priority date | — |
| Expiry date | Mar 17, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/4723
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions and methods for producing therapeutic oligomeric compounds. In one aspect the invention relates to methods for administering the oligomeric compounds for the treatment and prevention of disease, for example, a fungal infection, bacterial infection, or cancer, in a mammal. In particular, the invention relates to medicaments comprising various novel oligomeric compounds and pharmaceutically acceptable salts thereof. The compounds of the invention may optionally be administered with at least one of a pharmaceutically acceptable excipient, pharmacologically active agent or a combination thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.